Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mu... Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. Show more
WILMETTE, Ill., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients...
WILMETTE, Ill., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer...
WILMETTE, Ill., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients...
WILMETTE, Ill., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients...
WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.8 | -15.5339805825 | 5.15 | 5.4406 | 3.17 | 8506550 | 3.95143056 | CS |
4 | 1.71 | 64.7727272727 | 2.64 | 5.4406 | 2.25 | 2258351 | 3.93914016 | CS |
12 | 0.675 | 18.3673469388 | 3.675 | 5.4406 | 1.719 | 843346 | 3.81627327 | CS |
26 | 0.5 | 12.987012987 | 3.85 | 5.4406 | 1.719 | 467948 | 3.80154638 | CS |
52 | 1.358 | 45.3877005348 | 2.992 | 8.65 | 1.3695 | 1842918 | 4.53647793 | CS |
156 | -20.8 | -82.703777336 | 25.15 | 28.7 | 1.3695 | 668147 | 4.73156713 | CS |
260 | -116.35 | -96.396023198 | 120.7 | 240 | 1.3695 | 455134 | 7.72849555 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.